Terry-Ann Burrell's Net Worth

$16.6 Million

Estimate Recalculated Nov 11, 2024 08:51AM EST

Who is Terry-Ann Burrell?

Terry-Ann Burrell has an estimated net worth of $16.6 Million. This is based on reported shares across multiple companies, which include Beam Therapeutics Inc., RECURSION PHARMACEUTICALS, INC., and Rapport Therapeutics, Inc..

SEC CIK

Terry-Ann Burrell's CIK is 0001786484

Past Insider Trading and Trends

2021 was Terry-Ann Burrell's most active year for acquiring shares with 13 total transactions. Terry-Ann Burrell's most active month to acquire stocks was the month of December. 2021 was Terry-Ann Burrell's most active year for disposing of shares, totalling 23 transactions. Terry-Ann Burrell's most active month to dispose stocks was the month of December. 2024 saw Terry-Ann Burrell paying a total of $1,342,000.00 for 162,600 shares, this is the most they've acquired in one year. In 2021 Terry-Ann Burrell cashed out on 749,999 shares for a total of $10,550,501.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Beam Therapeutics Inc. (BEAM) Snapshot price: $23.25

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.82%
12.5K
—
—
82.64K
Apr 26
Form 4
-7.21%
-5.45K
$32.12
-$174,925.52
70.14K
Apr 1
Form 4
+57.19%
27.5K
—
—
75.58K
Mar 31
Form 4
—
0
—
—
0
Jan 31
Form 4/A
—
0
—
—
0
Jan 31
Form 4
-8.96%
-4.64K
$29.74
-$137,978.26
47.12K
Apr 3 - Apr 4
Form 4
+63.94%
20K
—
—
51.28K
Jan 31 - Mar 31
Form 4
—
0
$29.38
-$1,169,875.14
31.28K
Scheduled
Jan 26 - Jan 27
Form 4
—
0
$29.35
-$634,118.77
31.28K
Scheduled
Jan 23 - Jan 24
Form 4
-18.94%
-7.31K
$29.41
-$1,584,741.82
31.28K
Scheduled
Jan 18
Form 4
+52.71%
13.21K
$59.11
-$105,629.57
38.28K
Mar 31
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
$67.84
-$3,249,600.00
24.81K
Scheduled
Jun 30
Form 4
—
0
$60.69
-$4,230,416.46
24.81K
Scheduled
Jun 28
Form 4
+239.43%
17.5K
—
—
24.81K
Mar 31
Form 4
—
0
$47.73
-$1,702,484.79
7.31K
Scheduled
Jan 4
Form 4
∞
7.31K
$13.68
$99,987.12
7.31K
Sep 18
Form 3
—
0
—
—
0
No matching records found

RECURSION PHARMACEUTICALS, INC. (RXRX) Snapshot price: $5.95

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.66%
1.84K
—
—
71.25K
Jul 1
Form 4
+23.26%
13.1K
—
—
69.41K
Jun 3
Form 4
+2.67%
1.47K
—
—
56.31K
Apr 1
Form 4
-68.08%
-117.00K
$12.07
-$1,412,413.53
54.85K
Jul 12 - Jul 13
Form 4
+7.92%
12.61K
—
—
171.85K
Jun 16
Form 4
+1.16%
1.82K
—
—
159.24K
Jan 3
Form 4
+0.81%
1.26K
—
—
157.41K
Oct 3
Form 4
+1.06%
1.63K
—
—
156.15K
Jul 1
Form 4
+13.31%
18.14K
—
—
154.52K
Jun 14
Form 4
+1.33%
1.79K
—
—
136.37K
Apr 1
Form 4
+0.57%
763
—
—
134.59K
Jan 3
Form 4
+0.47%
629
—
—
133.82K
Oct 1
Form 4
+0.29%
382
—
—
133.19K
Jul 1
Form 4
—
0
—
—
132.81K
Apr 20
Form 4
+5.19%
6.25K
—
—
126.56K
Apr 15 - Apr 16
Form 3
—
0
—
—
0
No matching records found

Rapport Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found